PYRIMETHAMINE LEUCOVORIN- pyrimethamine leucovorin capsule 
ImprimisRx PA, Inc. d/b/a ImprimisRx

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Pyrimethamine Leucovorin (50mg-20mg)

Pyrimethamine Leucovorin (50mg-20mg)

image description

PYRIMETHAMINE LEUCOVORIN 
pyrimethamine leucovorin capsule
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70271-429
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRIMETHAMINE (UNII: Z3614QOX8W) (PYRIMETHAMINE - UNII:Z3614QOX8W) PYRIMETHAMINE50 mg
LEUCOVORIN CALCIUM (UNII: RPR1R4C0P4) (LEUCOVORIN - UNII:Q573I9DVLP) LEUCOVORIN20 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) 70 mg
Product Characteristics
Colorgray, pinkScoreno score
ShapecapsuleSize15mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70271-429-01100 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/27/2015
Labeler - ImprimisRx PA, Inc. d/b/a ImprimisRx (080044737)

Revised: 11/2015
Document Id: 1f89552d-6994-4601-9f6b-43b3c7994d4b
Set id: 59d18949-cea3-4695-8253-66906659021b
Version: 1
Effective Time: 20151127
 
ImprimisRx PA, Inc. d/b/a ImprimisRx